New hope for kids with recurrent brain tumors: testing a targeted drug delivery
NCT ID NCT02774421
Summary
This early-phase study is testing a new way to treat children whose brain cancer (ependymoma) has come back. Researchers are giving a targeted drug directly into the spinal fluid, along with an immune-boosting shot, to see if the drug reaches the tumor and to check for side effects. The goal is to find a safe dose and see if this approach could help control the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTERIOR FOSSA EPENDYMOMA (PFEPN) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Hospital Colorado
Aurora, Colorado, 80045, United States
Conditions
Explore the condition pages connected to this study.